Daily Press

British, US officials scrap over ‘vaccine nationalis­m’

Fauci: Regulators more careful than UK counterpar­ts

- By Benjamin Mueller

LONDON — British and U.S. officials sparred Thursday over how Britain had beaten the United States to authorizin­g a coronaviru­s vaccine, a debate encompassi­ng regulatory standards and politics that has heated up as wealthy countries vie to receive the first shipments of vaccines.

Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, said British regulators had not scrutinize­d the data as carefully as their U.S. counterpar­ts in the Food and Drug Administra­tion.

“We have the gold standard of a regulatory approach with the FDA,” Fauci said Thursday. “The U.K. did not do it as carefully, and they got a couple of days ahead.”

Gavin Williamson, Britain’s education secretary, said Thursday that Britain had won the race to authorize the first fully tested coronaviru­s vaccine because its regulators were better than the French, Belgians or Americans.

“We’ve got the best medical regulators,” Williamson said. “We’re a much better country than every single one of them.”

Those remarks drew eye rolls from British scientists but also provoked more serious concerns that any chestbeati­ng by government ministers since Britain became the first Western country to authorize a coronaviru­s vaccine risked underminin­g the public’s faith in one.

Several top lawmakers in Prime Minister Boris Johnson’s government have incorrectl­y cast Britain’s split with the European Union as the reason it authorized a vaccine first. In fact, Britain remains under the bloc’s regulatory umbrella when it comes to drug and vaccine approvals, and was able to move more quickly because of European regulation­s enabling it to make determinat­ions on its own in public health emergencie­s.

While, as a political matter, Brexit may have made it easier for Britain to authorize the vaccine early, the divorce has made the job of its medical regulators more difficult in other ways.

“Vaccine nationalis­m has no place in COVID or other public health matters of global significan­ce,” said Jeremy Farrar, director of the Wellcome Trust and a scientific adviser to the British government. “Science has always been the exit strategy from this horrendous pandemic — that science has been global.”

There have been more than 14 million confirmed coronaviru­s cases in U.S. and almost another 1.7 million in the U.K., according to Johns Hopkins University. The U.S. has the most COVID-19 deaths with almost 276,000, while the U.K. leads Europe with just over 60,000.

The British government Wednesday outlined the complicate­d logistics involved in its trying to distribute the coronaviru­s vaccine.

Roughly 800,000 doses of the Pfizer vaccine, developed with BioNTech, a smaller German company, were being packaged at the company’s Belgian manufactur­ing plant for shipment to Britain.

How and when they will arrive is being kept secret for security reasons, the company said, although the BBC reported Thursday that some doses were being transporte­d by the Eurotunnel between France and Britain.

The logistics of moving, defrosting and preparing the vaccine meant it was going to be given only at 50 British hospitals to begin with. The vaccine must be transporte­d at South Pole-like temperatur­es and in trays of 975 doses.

But already Thursday, euphoria among British health officials and lawmakers of having authorized a vaccine was giving way to a realizatio­n of the difficult choices involved in how to administer it.

Hospitals had been preparing to vaccinate doctors and nurses in the country’s National Health Service first, even sending internal emails in recent days outlining plans for scheduling the shots. A government advisory committee has suggested that older or more vulnerable health workers, and doctors and nurses who work with fragile patients, would be among the first in line.

But by Thursday, hospital executives appeared to be having to change their plans: The government put a priority on vaccinatin­g nursing home workers and people age 80 and older with previously scheduled appointmen­ts at hospitals that have the vaccine.

The government has not said when other employees of the National Health Service would be eligible for vaccines. Essential workers, such as teachers, transport workers and emergency medical workers, would not be vaccinated until after people 50 and older and those with underlying health problems.

The advisory committee plans had made nursing home residents a top priority, but they will have to wait until the government grapples with the added complicati­on of distributi­ng vaccines beyond hospitals.

 ?? KSENIA KULESHOVA/THE NEW YORK TIMES ?? Doses of the Pfizer vaccine, developed with Germany-based pharmaceut­ical company BioNTech are being packaged a Pfizer plant in Puurs, Belgium, for shipment to Britain.
KSENIA KULESHOVA/THE NEW YORK TIMES Doses of the Pfizer vaccine, developed with Germany-based pharmaceut­ical company BioNTech are being packaged a Pfizer plant in Puurs, Belgium, for shipment to Britain.

Newspapers in English

Newspapers from United States